has been cited by the following article(s):
[1]
|
Biosimilars in oncology and inflammatory diseases: current and future considerations for clinicians in Latin America
mAbs,
2018
DOI:10.1080/19420862.2018.1484977
|
|
|
[2]
|
Development of New Formulations of Biologics: Expectations, Immunogenicity, and Safety for Subcutaneous Trastuzumab
Pharmaceutical Medicine,
2018
DOI:10.1007/s40290-018-0247-5
|
|
|